0001493152-22-030021.txt : 20221031 0001493152-22-030021.hdr.sgml : 20221031 20221031171730 ACCESSION NUMBER: 0001493152-22-030021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221027 FILED AS OF DATE: 20221031 DATE AS OF CHANGE: 20221031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gildea Edward J CENTRAL INDEX KEY: 0001389445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54433 FILM NUMBER: 221347139 MAIL ADDRESS: STREET 1: C/O CONVERTED ORGANICS INC. STREET 2: 7A COMMERCIAL WHARF WEST CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARIMED INC. CENTRAL INDEX KEY: 0001522767 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 274672745 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 OSSIPEE RD STREET 2: SUITE 201 CITY: NEWTON STATE: MA ZIP: 02464 BUSINESS PHONE: 617-795-5140 MAIL ADDRESS: STREET 1: 26 OSSIPEE RD STREET 2: SUITE 201 CITY: NEWTON STATE: MA ZIP: 02464 FORMER COMPANY: FORMER CONFORMED NAME: WORLDS ONLINE INC. DATE OF NAME CHANGE: 20110608 4 1 ownership.xml X0306 4 2022-10-27 0 0001522767 MARIMED INC. MRMD 0001389445 Gildea Edward J C/O MARIMED INC. 10 OCEANA WAY NORWOOD, MA 02062 1 0 0 0 Common stock 229391 D Restricted Stock Units (RSU) 2022-10-27 4 A 0 33333 0 A Common Stock, par value $.001 per share 33333 33333 D Option to buy common stock 0.88 2026-07-09 Common Stock, par value $.001 per share 100000 100000 D Option to buy common stock 0.9922 2024-09-27 Common Stock, par value $.001 per share 100000 100000 D Option to buy common stock 0.77 2022-12-31 Common Stock, par value $.001 per share 100000 100000 D The RSUs were granted to the Reporting Person in accordance with Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Each RSU represents a contingent right to receive one share of the Issuer's common stock. RSUs convert to common stock on a one-for-one basis. The RSUs fully vest on the six-month anniversary of the October 27, 2022 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. Immediately. /s/ Edward J. Gildea 2022-10-28